This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Ox bile extract
- DrugBank Accession Number
- DB14016
- Background
Not Available
- Type
- Biotech
- Groups
- Approved, Experimental, Investigational
- Synonyms
- Beef bile
- Bos bovis bile
- Bos taurus bile
- Bovine bile
- Fel tauri
- Ox bile
- Purified oxgall
- Sodium choleate
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to treat Cholecystopathy Combination Product in combination with: Activated charcoal (DB09278), Pancrelipase (DB00085) •••••••••••• ••••••• ••••••• •••••• Treatment of Chronic constipation ••• ••• Used in combination for symptomatic treatment of Dyspepsia Combination Product in combination with: Activated charcoal (DB09278), Pancrelipase (DB00085) •••••••••••• ••••••• ••••••• •••••• Treatment of Gallstones ••• ••• Treatment of Herpes zoster ••• ••• - Associated Therapies
- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAluminium phosphate The serum concentration of Ox bile extract can be decreased when it is combined with Aluminium phosphate. Aluminum chloride The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum chloride. Aluminum chlorohydrate The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum chlorohydrate. Aluminum hydroxide The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum hydroxide. Aluminum oxide The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum oxide. - Food Interactions
- Take after a meal.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Alka-pan Tablets Ox bile extract (35 mg) + Betaine hydrochloride (20 mg) + Bromelains (50 mg) + Pancrelipase (135 mg) + Papaya (125 mg) Tablet Oral Morter Healthsystem Not applicable Not applicable Canada 
Dygest Ox bile extract (75 mg) + Betaine hydrochloride (90 mg) + Pancrelipase (200 mg) + Papain (100 mg) + Peppermint (50 mg) + Pepsin (125 mg) Tablet Oral Creative Nutrition Canada Corp. 1987-12-31 2007-07-11 Canada Enzyme Tablets Ox bile extract (8.125 mg) + Betaine hydrochloride (65 mg) + Pancrelipase (100 mg) + Pancrelipase amylase (130 mg) + Papain (65 mg) + Pepsin (65 mg) Tablet Oral General Nutrition Canada Inc. 2001-10-20 2007-08-01 Canada FLATON ENTERIK DRAJE, 30 ADET Ox bile extract (25 mg) + Hemicellulase (50 mg) + Pancrelipase amylase (3150 FIP) + Pancrelipase lipase (1050 FIP) + Pancrelipase protease (210 FIP) + Simethicone (50 mg) Tablet, coated Oral BİLİM İLAÇ SAN. VE TİC. A.Ş. 1989-03-14 Not applicable Turkey 
FLATON ENTERIK DRAJE, 60 ADET Ox bile extract (25 mg) + Hemicellulase (50 mg) + Pancrelipase amylase (3150 FIP) + Pancrelipase lipase (1050 FIP) + Pancrelipase protease (210 FIP) + Simethicone (50 mg) Tablet, coated Oral BİLİM İLAÇ SAN. VE TİC. A.Ş. 1989-03-14 Not applicable Turkey - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Stozyme Ox bile extract (5.21 1/1001) + Dimethicone (5.21 1/1001) + Hemicellulase (10.42 1/1001) + Pancrelipase (36.46 1/1001) Tablet Oral Chunwoo Pharmaceutical Co., Ltd. 2019-10-19 Not applicable US 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- ET3651ZLOU
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Completed Treatment Obesity / Overweight / Type 2 Diabetes Mellitus 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Oral Tablet, coated Oral Tablet Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
Drug created at April 25, 2018 22:43 / Updated at September 28, 2021 21:54